Medartis Revenue and Competitors

USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Medartis's estimated annual revenue is currently $213.9M per year.(i)
  • Medartis's estimated revenue per employee is $251,000

Employee Data

  • Medartis has 852 Employees.(i)
  • Medartis grew their employee count by 2% last year.

Medartis's People

NameTitleEmail/Phone
1
Area VP Sales, Western USReveal Email/Phone
2
Assistant CTO & VP EMEAReveal Email/Phone
3
Controller CoordinatorReveal Email/Phone
4
Head Packaging & LabelingReveal Email/Phone
5
Head HR SwitzerlandReveal Email/Phone
6
Head Sales CMF JapanReveal Email/Phone
7
VP SalesReveal Email/Phone
8
Head Sales - UKReveal Email/Phone
9
Head EducationReveal Email/Phone
10
VP EMEAReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5M40-18%$10MN/A
#2
$24.8M9929%N/AN/A
#3
$84.1M0N/A$1.2MN/A
#4
$35.6M14230%N/AN/A
#5
$57.5M2296%N/AN/A
#6
$52.7M16825%$129.6MN/A
#7
$21.1M84-3%N/AN/A
#8
$61.2M244-13%N/AN/A
#9
$60.6M19320%$115.5MN/A
#10
$56.2M179-3%$122.9MN/A
Add Company

What Is Medartis?

At Medartis, we develop, manufacture and distribute titanium screws and plates, surgical instruments and system solutions for fracture fixation. Headquartered in Basel, Switzerland, our company is represented worldwide through our eleven subsidiaries and a wide distributor network.\n\nWe place the highest priority on maintaining stringent quality standards, continuous development and innovation, including comprehensive service provision for physicians, operating-room (OR) staff and patients. Our long-term customer relations based on partnerships have formed the foundation for our sustainable success since the company’s founding. \n\nDr. h.c. Thomas Straumann founded Medartis in 1997 and returned to the field of osteosynthesis in cranio-maxillofacial surgery. Our product portfolio was expanded in 2004 with the APTUS Hand and Distal Radius systems. This paved the way for a successful entry into orthopedics.\n\nAll Medartis products are developed in close consultation with hand and traumatology specialists as well as experienced OR teams. Our goal is to continually improve early functional rehabilitation through our high-quality products and exclusively developed technologies.

keywords:N/A

N/A

Total Funding

852

Number of Employees

$213.9M

Revenue (est)

2%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Medartis News

2022-04-19 - Outlook on the Hip Replacement Implants Global Market to 2027 - Rising Geriatric Populations are Driving Growth - ResearchAndMarkets.com

Medartis Holding AG. Scroll to continue with content. Ad. ADVERTISEMENT. Diabetes, obesity, hip disorders such as osteoarthritis,...

2022-04-17 - Global Jaw Implant Market 2022-2028 Recent Industry ...

Medartis; Eurosurgical; Guangzhou Wanhe Plastic Materials; Johnson & Johnson; TMJ Concepts; Zimmer-Biomet; Implantech; Spectrums Design Medical...

2022-04-06 - The recent pullback must have dismayed Medartis Holding AG (VTX:MED) insiders who own 54% of the company

What Does The Institutional Ownership Tell Us About Medartis Holding? Institutional investors commonly compare their own returns to the returns...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$272M85251%N/A
#2
$293.4M85214%N/A
#3
$214.7M85211%N/A
#4
$262.7M85310%N/A
#5
$298.6M853N/AN/A